CardioMEMS develops wireless sensing and communication technology solutions for severe chronic cardiovascular diseases in the human body.
CardioMEMS is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. Their technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure and aneurysms. Their miniature wireless sensors can be implanted using minimally invasive techniques and transmit cardiac output, blood pressure and heart rate data that are critical to the management of patients.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 10, 2010 | Series Unknown | $37.88M | 2 | — | — | Detail |
Oct 9, 2009 | Series F | $22.10M | 2 | — | — | Detail |
Nov 4, 2006 | Series D | $22.60M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Medtronic | — | Series Unknown |
Rockport Venture Partners | — | Series Unknown |